Valuable Drugs Possibly not Billed To your Decreased Money End user

There have been many new biological drugs approved by the FDA to take care of psoriasis since 2003 as one of these of an inflated drug price that many lower income people can’t get access to because Medicaid and Medicare won’t purchase them because of the skyrocketing prices. The newest blood thinner “Eliquis” is covered by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new are also covered by the government without hesitation in your community of $150 a pop. Some states purchase the very expensive $400 and above hearing aids and some don’t. So why aren’t the brand new biological drugs that came out to take care of psoriasis since 2003 covered by the government?

I guess that is one moment where I’m planning to answer the question I simply asked of this articles readers. In the above linked article I posted to go with this particular article the author states these biological drugs to take care of psoriasis will NOT be offered to people that are on Medicaid and Medicare due to price. All of the drug companies who have created their own biological psoriasis treatments have pushed people on Medicaid and Medicare far from receiving treatment with your drugs through the high cost of the drugs. Medicare Part D prescription drug plan will probably pay the bulk cost of “biological’s” but the co pay is between $1200 and $5000 which still keeps people from getting the biological’s.

The spin is a few of these biological drug companies have programs to provide the drugs absolve to low income patients who have private insurance only. Drug companies have stated in several articles I’ve read when the patients have Medicare or Medicaid they will NOT be entitled to the free programs.

Quote From The cheapest GoodRx price for the most frequent version of Humira is about $5,130.76, 38% off the common retail price of $8,309.04.

These biological psoriasis treatments are not life saving so Medicare and Medicaid do not recognize the inflated cost by drug companies as a necessary expense. The drug companies know this and are interested this way. Back 2003 when these biological psoriasis treatments were entering the drug marketplace they certainly were affordable and insurance companies picked up the expense if your reasonable deductible was paid. After 2012 the insurance companies started to get rid of people who have psoriasis since the payouts on the biological treatments were rising and getting extremely expensive.
The “Epipen Injector” used to take care of heroin overdoses was attacked viciously by the U.S. government when the master of the organization jacked up the cost so high only the truly wealthy could afford them. Medicaid and Medicare in certain states do cover generic Epipen’s but reject brand names. I’ve arrived at my conclusion about why this and other high drug prices are happening that keep a few of these drugs out from the reach of numerous people that are on Medicare and Medicaid.

Come ON! of course it’s collusion involving the “Big Pharma” drug industry and members of congress. But once the collusion deals go south it’s the drug industry that’s forced to take the fall.

When these scams to achieve personal wealth arrived at light as in the opioid epidemic that’s ongoing now where billions of dollars are increasingly being paid out by the drug companies to the states our congressional representatives who profited from opioids though insider trading investments walk around without any chance of repercussion because of their involvement in the scheme.

If you look at Canada which is really a country where government has to pay for ALL healthcare costs you will see the lowest prices on quality drugs anywhere because the government forces prices down to reduce government expenditures. All of the drug companies that come up with high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought far from destroying excessive profit taking by the drug companies as they are invested in these drug companies for their own personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I simply bet ya if your person gained usage of the investments of our congressional leaders they would find many instances of drug company investments who have extremely high drug prices on popular needed drugs that actually work to improve a persons health. Congress voted to offer drug companies a 20 year patent before generics could be produced with a 5 year extension if certain conditions are met knowing that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time has become 12 years but I haven’t seen this 12 year patent time frame in “Wikipedia” or anywhere else. All I see are 20 year patent time frames. I searched around and learned following the drug is invented and a patent applied it could take around 8 years to have FDA approved which leaves 12 years for the drugs to remain on a patent.

Which of our congressional representatives would vote against this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they may increase their own personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs for instance since they have only been with us since 2003 or so. “Humira” was the initial biological patent approved by the FDA for the treatment of Rheumatoid Arthritis. Afterwards “Humira” was approved for the treatments of many other medical conditions including psoriasis.

When there is a 20 year patent on these drugs then “Humira” is likely to be priced out of reach of the general public until 2023 that has been a massive profit taking window for congressional representatives. “Skyrizi” that will be new this year in 2019 is priced around “$15,000” for a 12 months kit that will be 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” removes 90% of psoriasis with the initial two shots which are 4 weeks apart. “Skyrizi” will stay priced quite high until about 2039 when it includes a 20 year patent.

When Humira comes from patent in 2023 it will send the manufacturing of it to the generic drug companies and drop the cost to advertise value that might mean everyone on Medicaid and Medicare may have an opportunity to be treated with it. All biological drug manufacturers will have to drop their prices also to a reasonable level because ALL doctors will direct their patents to Humira leaving other drug companies with a product that can not be sold due to price. In “India” a common type of “Humira” has been manufactured and the monthly cost is $400 that will be only down a hundred or so from the discounted prices in the U.S.. wocklean  After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it could cost a drug company over a thousand dollars to produce a drug but that is “Bull Hicky” ;.For one think a drug company isn’t a drug company without a team of researchers. In fact a drug company is nothing but researchers. A drug company after it starts building a benefit from the drugs they produced in the initial place has to budget for a permanent research team to produce future drug profits. The research team gets its paychecks from previous released drug sales always and forever and NO recouping of costs for the development of a brand new drug is ever needed. A drug company is just a huge laboratory saturated in scientists that receives a commission regularly to produce new drugs and do constant experiments. No extra financial outputs are going on to drive drug prices through the roof.

Popular new releases of drugs are simply total profit magnets for drug companies and congressional representatives. It’s like the city or city your home is for making you believe that the price to deal with a concern will exceed the taxes already collected to pay for the staff and resources to deal with the problems that happen to be funded.

The “Stock Act” was enacted on April 4th, 2012 which required every person in congress to post their investment transactions on their websites within 45 days of making them for public viewing. Congressional representatives do not want their investments looked at however when public demand dictated so it become law to possess their investments made public they’d to offer into people demand and folded to it. Following a year congress went against public demand on April 15th 2013 and voted to kill the parts of the law that would make their investments public. Congress could not fulfill themselves at the cost of U.S. Citizens with riches galore through insider trading which they think they have a right to accomplish since there’s no legal entity which will punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced lower in 2012 and insurance companies covered them if a reasonable deductible was paid by someone who had a great job. After the market for biological,s started to develop the market became hijacked by the wealthy as an easy way to increase their personal values by increasing the values and marketing these drugs to the wealthy and themselves who’re the wealthy for massive profit taking. People have been getting their psoriasis drugs covered through their insurance companies were being dropped off their insurance plans. Even though insurance carriers covered biological’s before 2012 low income Medicaid and Medicare patients still didn’t have usage of these drugs. Medicare Part D prescription plan pays the bulk of cost but the copay is $1200 to $5000 dollars which means most Medicare patients do not have usage of biological’s.

There’s no other way you will look at it. “Epipen’s” were getting the exact same treatment, they certainly were introduced at a lowered price then hijacked available only to the wealthy which would produce high profits with decreased production costs. I keep running in to the hearing aid problems that were suppose to possess been priced in to the 1000s of dollars then being reduced to under $700 that will be still to expensive and a world of massive profit taking. Advanced computer parts are cheaper than hearing aids?

With these drug companies as is with any business who holds a monopoly on any needed or popular product through government mandate the larger prices only the wealthy can pay are dictated which means less production is likely to be needed that translates into lower production costs and the exact same or older profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post